Market Tracker

04/23 8:26am ET

Incyte Corp (NASDAQ:INCY)

49.32
Data as of Apr 22
 +1.87 / +3.94%
Today’s Change
18.23
Today|||52-Week Range
70.86
-2.59%
Year-to-Date

Today’s Trading

Previous close47.45
Today’s open47.58
Day’s range-- - --
Volume2,519,688
Average volume (3 months)2,217,026
Market cap$7.4B
Dividend yield--
Data as of 04/22/2014

Growth & Valuation

Earnings growth (last year)-64.71%
Earnings growth (this year)+17.55%
Earnings growth (next 5 years)+83.94%
Revenue growth (last year)+19.49%
P/E ratioNM
Price/Sales21.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...+0.36+0.85%
HSPHospira Inc+0.54+1.25%
JAZZJazz Pharmaceuticals...+7.02+5.07%
PCYCPharmacyclics Inc+4.37+4.91%
Data as of 04/22/2014

Financials

Next reporting dateMay 1, 2014
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$354.9M
Annual profit (last year)-$83.1M
Net profit margin-23.43%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David C. Hastings
Corporate headquarters
Wilmington, Delaware

Forecasts